StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) stock

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.48−0.14 (-8.64%)

Close on Nov 16, 2026Market cap $55.39MP/E –Yield –

Tenax Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Tenax Therapeutics's total debt was $31.08K at Mar 31, 2021. For fiscal 2020 it was $124.17K. The highest annual figure on record is $4.46M in fiscal 2011.

Annual total debt

PeriodPeriod endValueChange
FY2020Dec 31, 2020$124.17K–
FY2019Dec 31, 2019$0–
FY2014Apr 30, 2014$0-100.0%
FY2013Apr 30, 2013$2.99M+120.0%
FY2012Apr 30, 2012$1.36M-69.5%
FY2011Apr 30, 2011$4.46M–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2021CQ1 2021Mar 31, 2021$31.08K–
Q4 FY2020CQ4 2020Dec 31, 2020$124.17K–
Q3 FY2020CQ3 2020Sep 30, 2020$213.76K–
Q2 FY2020CQ2 2020Jun 30, 2020$137.05K–
Q4 FY2019CQ4 2019Dec 31, 2019$0–

More Tenax Therapeutics figures

See a number that looks wrong?